Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 2

Conditions: Irritable Colon

Treatments: Drug: GW876008

Study type: Interventional

Funder types: Industry

Identifiers

NCT00385099

CRI103143

Details and patient eligibility

About

The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.

Enrollment: 10 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must have irritable bowel syndrome.

Exclusion criteria

• Subjects who have been taking any medication for the treatment of irritable bowel syndrome within 6 months prior to the start of the study.